Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability
2019-09-30 18:29
Ascletis Announces Departure of Chief Financial Officer
2019-09-30 16:30
Ascletis Announces Departure of Chief Financial Officer
2019-09-30 16:30
First Digital Health Osteoarthritis Wearable Glove System Starts Pre-launch Pilot Trial Series & Medical Tests
2019-09-30 16:04
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis
2019-09-30 15:00
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019
2019-09-30 13:41
The 10th China (Taizhou) International Medical Expo successfully ended
2019-09-30 13:27
New Major Order From China
2019-09-30 11:45
Osteopore debuts on ASX, taking its unique 3D bone implant printing global
2019-09-30 09:00
Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App
2019-09-30 09:00
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019
2019-09-30 06:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal
2019-09-30 05:00
From broadcast gymnastics to national fitness
2019-09-29 21:00
Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer
2019-09-29 12:13
On World Heart Day, 29 September 2019, the World Heart Federation (WHF) Calls for Heart Health Equity Because Every Heartbeat Matters
2019-09-27 20:05
Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China
2019-09-27 18:52
Bactiguard Signs Global License Agreement With Zimmer Biomet
2019-09-27 14:16
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019
2019-09-27 14:00
TUV Rheinland: Notified Body for the New Medical Device Regulation
2019-09-27 11:00
AIT Worldwide Logistics' Life Sciences Control Tower earns Good Distribution Practices certification
2019-09-27 02:02
1
862
863
864
865
866
1596